Related Experiment Video

Updated: Jun 20, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Cancer/testis antigens for therapeutic use

M G Mathieu1, A K Miles, G Li

  • 1The John van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Nottingham, UK. morgan.mathieu2@ntu.ac.uk

Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|September 29, 2009
PubMed

Insights

Researchers investigated T21 and HAGE, two novel cancer/testis antigens, for their expression, role in tumor development, and immunogenic potential as potential cancer immunotherapies.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Cancer/testis antigens are a promising source for cancer immunotherapies.
  • The MAGE family includes well-studied tumor-associated antigens.
  • Identifying novel targets is crucial for advancing cancer treatment.

Purpose of the Study:

  • To evaluate the expression profile of T21 and HAGE in various normal and cancerous tissues.
  • To investigate the potential role of T21 and HAGE in tumor cell development and proliferation.
  • To assess the immunogenic potential of T21 and HAGE for therapeutic applications.

Main Methods:

  • Expression analysis across diverse tissue types (normal and tumor).
  • Functional studies to determine the role in tumor cell biology.
  • Immunogenicity assays to evaluate potential as therapeutic targets.

Main Results:

  • Detailed expression patterns of T21 and HAGE identified.
  • Insights into the involvement of these antigens in tumor progression.
  • Assessment of their immunogenic properties for immunotherapy.

Conclusions:

  • T21 and HAGE represent novel cancer/testis antigens with significant potential.
  • Their specific expression and immunogenicity warrant further investigation for cancer immunotherapy development.

More Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

An Orthotopic Bladder Cancer Model for Gene Delivery Studies07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...